Replies to post #60292 on Biotech Values

[DewDiligence]

>Are you thinking competition from future DTIs and factor Xa inhibitors?<

Yes, of course. Moreover, the new genetic test for P450 is potentially problematic for the ARYX drug. You must have noticed how uncomfortable management was in addressing this issue on the CC.